Neurally mediated cardiac effects of forskolin in conscious dogs

M Iwase1, Y Ishikawa, Y T Shen

  • 1Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston 02115, USA.

Insights

Forskolin enhances heart function through direct adenylyl cyclase activation and neural pathways. These effects are modulated by sympathetic tone and blocked by beta-adrenergic receptors in conscious dogs.

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology

Background:

  • Cardiovascular diseases involve adenylyl cyclase regulation defects.
  • Understanding adenylyl cyclase activators' effects on heart function is crucial.

Purpose of the Study:

  • To investigate the inotropic and chronotropic effects of forskolin in conscious dogs.
  • To elucidate the role of neural mechanisms and sympathetic tone in forskolin's actions.

Main Methods:

  • Administered forskolin and NKH-477 to normal and ventricular denervated dogs.
  • Utilized ganglionic blockade, atropine, and beta-adrenergic blockade.
  • Measured left ventricular pressure derivative (LV dP/dt) and norepinephrine levels.

Main Results:

  • Forskolin increased LV dP/dt and heart rate, with attenuated effects in denervated dogs and after ganglionic blockade.
  • Beta-adrenergic blockade and morphine further reduced forskolin's effects.
  • In vitro studies showed direct adenylyl cyclase activation unaffected by beta-blockade.

Conclusions:

  • Forskolin's inotropic and chronotropic effects in conscious dogs involve both direct adenylyl cyclase activation and neural mechanisms.
  • Sympathetic tone potentiates forskolin's cardiac effects.
  • Neural pathways and sympathetic tone significantly contribute to forskolin's cardiovascular actions.